Antz Christoph Rudiger
Chief Executive Officer
Antz Christoph Rudiger has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Aug 31, 2026.
On the most recent filing, Antz Christoph Rudiger is listed as Chief Executive Officer at Veraxa Biotech AG - Post de-SPAC. Inside the rolling window, Antz Christoph Rudiger reported 1 open-market purchase totaling $8K in VRXA and no open-market sales.
Companies traded
Other insiders at VRXA
Insider Buying
$8K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Antz Christoph Rudiger made?
Antz Christoph Rudiger has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Antz Christoph Rudiger trade?
Antz Christoph Rudiger has filed SEC Form 4 disclosures for 1 company, including VRXA.
When was Antz Christoph Rudiger's most recent SEC Form 4 filing?
Antz Christoph Rudiger's most recent SEC Form 4 filing on Tracefour is dated Aug 31, 2026.
What is Antz Christoph Rudiger's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Antz Christoph Rudiger is listed as Chief Executive Officer.
What is Antz Christoph Rudiger's total buy and sell value in the current window?
Inside the rolling retention window, Antz Christoph Rudiger bought $8K and sold $0 based on SEC Form 4 filings.
What was Antz Christoph Rudiger's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 5,000 VRXA shares on 2026-08-27, worth $8K, per SEC Form 4 filings.